Inhibition of Cyclin-Dependent Kinase 8/Cyclin-Dependent Kinase 19 Suppresses Its Pro-Oncogenic Effects in Prostate Cancer-Reference-Cited by-同舟云学术

Inhibition of Cyclin-Dependent Kinase 8/Cyclin-Dependent Kinase 19 Suppresses Its Pro-Oncogenic Effects in Prostate Cancer

Published:2022-05 Issue:5 Volume:192 Page:813-823
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Offermann Anne,Joerg Vincent,Becker Finn,Roesch Marie C.,Kang Duan,Lemster Anna-Lena,Tharun Lars,Behrends Jochen,Merseburger Axel S.,Culig Zoran,Sailer Verena,Brägelmann Johannes,Kirfel Jutta,Perner Sven

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference29 articles.

1. Transcriptional addiction in cancer;Bradner;Cell,2017

2. The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation;Malik;Nat Rev Genet,2010

3. Transcription regulation by the Mediator complex;Soutourina;Nat Rev Mol Cell Biol,2018

4. Comparative genomics supports a deep evolutionary origin for the large, four-module transcriptional mediator complex;Bourbon;Nucleic Acids Res,2008

5. Pan-cancer analysis of the Mediator complex transcriptome identifies CDK19 and CDK8 as therapeutic targets in advanced prostate cancer;Brägelmann;Clin Cancer Res,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MED12 and CDK8/19 Modulate Androgen Receptor Activity and Enzalutamide Response in Prostate Cancer;Endocrinology;2024-08-27

2. Unveiling the impact of CDK8 on tumor progression: mechanisms and therapeutic strategies;Frontiers in Pharmacology;2024-03-28

3. Mediator kinase inhibition reverses castration resistance of advanced prostate cancer;Journal of Clinical Investigation;2024-03-28

4. Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers;Journal of Clinical Investigation;2024-03-26

5. Updates on Overcoming Bicalutamide Resistance: A Glimpse into Resistance to a Novel Antiandrogen;ACS Pharmacology & Translational Science;2024-03-07